Article Correctness Is Author's Responsibility: New study: ‘Double decker’ antibody technology fights cancer

(Scripps Research Institute) Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates for cancer therapy.